Dorzolamide-timolol 2-0.5%(PF) 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F7NJX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,513
Award facts
- Contract value 100% obligated
- $13,513.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,513.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Dorzolamide-Timolol 2-0.5% (preservative-free) in a 60-unit package. The contract carries an ultimate completion date of January 7, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a single transaction within a larger pharmaceutical supply framework serving federal military and healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999 million through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. The Dorzolamide-Timolol product supplied under this order is an ophthalmic medication used in the treatment of glaucoma and ocular hypertension, reflecting the company's role as a critical vendor for diverse pharmaceutical commodities across multiple therapeutic domains serving the Department of Defense and its healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F7NJX?
SPE2DR26F7NJX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F7NJX worth?
The government has obligated $13,513 on SPE2DR26F7NJX.
Is contract SPE2DR26F7NJX an order under another contract?
Yes. SPE2DR26F7NJX is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7NJX competed?
The extent of competition for SPE2DR26F7NJX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award